Patent · US Active

Method of treating prader-willi syndrome

US10441627B2 · kind B2 · utility

1Cited by

7References

23Claims

0Family size

Assignee

Ferring B.V. · NL

Inventors

Pascal Danglas · Saint-Prex, CH
Michael REIDY · Seattle, US
Paul KORNER · Franklin Lakes, US
Sudarkodi Alagarsamy · Millburn, US

Key dates

Filing date	Sep 14, 2015
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Sep 14, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.